These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19020843)

  • 21. Secondary mutations in viruses resistant to HIV-1 integrase inhibitors that restore viral infectivity and replication kinetics.
    Nakahara K; Wakasa-Morimoto C; Kobayashi M; Miki S; Noshi T; Seki T; Kanamori-Koyama M; Kawauchi S; Suyama A; Fujishita T; Yoshinaga T; Garvey EP; Johns BA; Foster SA; Underwood MR; Sato A; Fujiwara T
    Antiviral Res; 2009 Feb; 81(2):141-6. PubMed ID: 19027039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombination, selection and clock-like evolution of Rice yellow mottle virus.
    Pinel-Galzi A; Mpunami A; Sangu E; Rakotomalala M; Traoré O; Sérémé D; Sorho F; Séré Y; Kanyeka Z; Konaté G; Fargette D
    Virology; 2009 Nov; 394(1):164-72. PubMed ID: 19740507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relating sequence evolution of HIV1-protease to its underlying molecular mechanics.
    Hamacher K
    Gene; 2008 Oct; 422(1-2):30-6. PubMed ID: 18590806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Did DNA come from viruses?
    Zimmer C
    Science; 2006 May; 312(5775):870-2. PubMed ID: 16690855
    [No Abstract]   [Full Text] [Related]  

  • 25. Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants.
    Quan Y; Liang C; Brenner BG; Wainberg MA
    J Infect Dis; 2009 Nov; 200(9):1479-83. PubMed ID: 19758098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal viral production.
    Coombs D; Gilchrist MA; Percus J; Perelson AS
    Bull Math Biol; 2003 Nov; 65(6):1003-23. PubMed ID: 14607286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction and tropism characterisation of recombinant viruses exhibiting HIV-1 env gene from seminal strains.
    Lawrence P; Berlier W; Delezay O; Palle S; Olivier T; Saoudin H; Mottin S; Lucht F; Pozzetto B; Bourlet T
    Virology; 2009 Apr; 386(2):373-9. PubMed ID: 19232661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
    Buzón MJ; Marfil S; Puertas MC; Garcia E; Clotet B; Ruiz L; Blanco J; Martinez-Picado J; Cabrera C
    Antivir Ther; 2008; 13(7):881-93. PubMed ID: 19043922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular biology of HIV.
    Barbosa P; Kneass Z
    Clin Podiatr Med Surg; 1998 Apr; 15(2):189-202. PubMed ID: 9576049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The HIV-1 leader RNA is exquisitely sensitive to structural changes.
    van Bel N; Ghabri A; Das AT; Berkhout B
    Virology; 2015 Sep; 483():236-52. PubMed ID: 25989234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viral fitness implications of variation within an immunodominant CD8+ T-cell epitope of HIV-1.
    Christie NM; Willer DO; Lobritz MA; Chan JK; Arts EJ; Ostrowski MA; Cochrane A; Luscher MA; MacDonald KS
    Virology; 2009 May; 388(1):137-46. PubMed ID: 19368950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspectives and opportunities for novel antiviral treatments targeting virus fitness.
    Clementi M
    Clin Microbiol Infect; 2008 Jul; 14(7):629-31. PubMed ID: 18190573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay.
    Garcia JM; Gao A; He PL; Choi J; Tang W; Bruzzone R; Schwartz O; Naya H; Nan FJ; Li J; Altmeyer R; Zuo JP
    Antiviral Res; 2009 Mar; 81(3):239-47. PubMed ID: 19118579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of population bottlenecks in an RNA virus evolving at increased error rate.
    Cases-González C; Arribas M; Domingo E; Lázaro E
    J Mol Biol; 2008 Dec; 384(5):1120-9. PubMed ID: 18951905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping of determinants involved in the stimulation of HIV-1 expression by Sam68.
    McLaren M; Cochrane A
    Virology; 2009 Mar; 385(1):93-104. PubMed ID: 19091369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-1 reverse transcription: close encounters between the viral genome and a cellular tRNA.
    Abbink TE; Berkhout B
    Adv Pharmacol; 2007; 55():99-135. PubMed ID: 17586313
    [No Abstract]   [Full Text] [Related]  

  • 37. High-throughput profiling of point mutations across the HIV-1 genome.
    Al-Mawsawi LQ; Wu NC; Olson CA; Shi VC; Qi H; Zheng X; Wu TT; Sun R
    Retrovirology; 2014 Dec; 11():124. PubMed ID: 25522661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No evidence of selection for mutational robustness during lethal mutagenesis of lymphocytic choriomeningitis virus.
    Martín V; Grande-Pérez A; Domingo E
    Virology; 2008 Aug; 378(1):185-92. PubMed ID: 18572218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simple quasispecies models for the survival-of-the-flattest effect: The role of space.
    Sardanyés J; Elena SF; Solé RV
    J Theor Biol; 2008 Feb; 250(3):560-8. PubMed ID: 18054366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current notions of genotype and phenotype vis-à-vis new experimental evidence in molecular biology. A methodological study instigated by the peculiar nature of the HIV-1.
    Torres JM
    Riv Biol; 1993; 86(2):155-9, 181-96. PubMed ID: 7939153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.